PI3K mutations are associated with improved DFS in colon cancer patients who received adjuvant therapy and improved radiosensitivity in patients undergoing yttrium 90 radioembolization [45, 46]. The gene discussed is PIK3CG; the disease is malignant colon neoplasm.